Wnt-targeted hair loss treatment
Scope
Date
~
-
Bio & Pharma
OliX's hair loss treatment candidate approved for clinical trial in Australia
South Korea's OliX Pharmaceuticals has received approval from Australia's Human Research Ethics Committees (HREC) to plan a phase 1 clinical trial o...
Mar 10, 2023 (Gmt+09:00)
-
Central bank
BOK chief defies rate cut calls amid sustained inflation
South Korean central bank chief on Tuesday defied calls for an interest rate cut this year despite growing risks of a recession in Asia’s four...
Mar 08, 2023 (Gmt+09:00)
-
Travel & Leisure
KTO promotes travel to Korea in ITB Berlin
The Korea Tourism Organization announced on Monday its participation in ITB Berlin 2023, the world's largest tourism fair held in Berlin, Germany, f...
Mar 07, 2023 (Gmt+09:00)
-
Sovereign wealth funds
S.Korea's KIC to strengthen responsible investments
Korea Investment Corporation (KIC) plans to actively voice its opinions on portfolio companies' management over the next two years to tighten its re...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada
Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...
Mar 06, 2023 (Gmt+09:00)
-
Pension funds
S.Korea's NPS likely to log 8.2% loss for 2022, record-low return
South Korea’s National Pension Service (NPS) is expected to post a negative return of 8.2% for 2022, according to its preliminary report on Th...
Mar 02, 2023 (Gmt+09:00)
-
Economy
S.Korea’s exports drop for 5th straight month in Feb on plunging chip sales
South Korea’s exports shrank 7.5% year over year in February on a plunge in shipments of its mainstay export item semiconductors amid the glob...
Mar 02, 2023 (Gmt+09:00)
-
Pension funds
S.Korea's GEPS logs 10.2% return on alternative assets in 2022
South Korea’s Government Employees Pension Service (GEPS) had a 4.4% loss on investment last year, seeing its assets under management (AUM) dr...
Mar 01, 2023 (Gmt+09:00)
-
Retail
China's CDFG targets duty free operation at Incheon Airport
China Duty Free Group Co. (CDFG), the only state-owned duty free business manager in China, has joined a bid alongside four South Korean retail gian...
Feb 27, 2023 (Gmt+09:00)
-
Automobiles
Bangladesh: Hyundai’s next target for partially assembled Tucson SUV
Bangladesh has long been a tough market for South Korean automakers to break into, given the decades-old dominance of Japanese carmakers such as Toy...
Feb 27, 2023 (Gmt+09:00)
-
Artificial intelligence
Kakao Brain to launch investment fund for AI startups
Kakao Brain, a South Korean artificial intelligence (AI) company owned by Kakao Corp., said on Sunday it plans to set up a fund of up to 10 billion ...
Feb 27, 2023 (Gmt+09:00)
-
Shareholder activism
KT&G potential target of aggressive activist shareholder
KT&G Corp., the world’s fifth-largest tobacco maker, is likely to face a tougher battle against activist shareholders as an aggressive hed...
Feb 22, 2023 (Gmt+09:00)
-
Korean startups
Blind revamps job matching service to rival LinkedIn
Teamblind Inc., the developer of South Korea’s homegrown anonymous professional community app Blind, will reach out to a broader job-seeking p...
Feb 20, 2023 (Gmt+09:00)
-
AgTech
Korea's Daedong to speed up growth with smart farming machines
Daedong Corp., South Korea’s top agricultural machinery manufacturer, aims to accelerate growth based on new businesses such as smart machines...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
AIMMED’s Somzz ushers in digital therapeutic device market in Korea
South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
LG Innotek targets XR device market with new substrate
South Korea’s LG Innotek Co. aims to lead the market for components of the extended reality (XR) device industry, which is expected to surge b...
Feb 15, 2023 (Gmt+09:00)
-
Sovereign wealth funds
Korean sovereign wealth fund KIC logs record loss in 2022
Sovereign wealth fund Korea Investment Corporation (KIC) posted the largest annual loss last year since its inception in 2005, according to its 20...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N's GERD drug K-CAB gets approval in Mexico
South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma, Janssen Korea sign sales, distribution agreement
SK Plasma Co. Ltd., a South Korean company specializing in the production of plasma derivatives from human plasma, is expanding its product portfoli...
Feb 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Shareholder activism
Activist fund KCGI to sell Osstem stake to UCK, MBK Partners
Korea Corporate Governance Improvement Fund (KCGI), one of the country’s most aggressive shareholder activists, plans to sell its stake in Oss...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB’s Rivoceranib, Hengrui's Camrelizumab approved as combination therapy in China
South Korea's HLB Co. announced on Thursday that the combination therapy of its drug candidate rivoceranib and Jiangsu Hengrui Pharmaceuticals Co., ...
Feb 09, 2023 (Gmt+09:00)
-
Earnings
Fintech firm Kakao Pay logs first yearly net profit in 2022
Kakao Pay Corp., the mobile payment service unit of South Korean tech giant Kakao Corp., posted a net profit last year for the first time since its ...
Feb 08, 2023 (Gmt+09:00)
-
Earnings
Korea refiners swing to Q4 loss amid windfall tax calls
South Korean refiners such as SK Innovation Co. and S-Oil Corp. are estimated to incur a combined loss of over 1 trillion won ($800 million) in the ...
Feb 07, 2023 (Gmt+09:00)
-
Electronics
Samsung, LG Elec target N.American air conditioner market at trade show
Samsung Electronics Co. and LG Electronics Inc. are vying for the North American market for air conditioners with their cutting-edge solutions in th...
Feb 07, 2023 (Gmt+09:00)
-
Earnings
SKC eyes M&As in semiconductor, rechargeable battery materials
SKC Inc., a South Korean chemical materials company under SK Group, is seeking to buy semiconductor and rechargeable battery materials companies in ...
Feb 06, 2023 (Gmt+09:00)
-
Carbon neutrality
SK Ecoplant passes industry-first carbon reduction target verification
South Korea's construction and engineering company SK Ecoplant Co. said on Thursday that it has passed the greenhouse gas reduction target verificat...
Feb 03, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
MBK, Unison to expand Osstem Implant's target reach beyond China
South Korean private equity firm Unison Capital Korea is set to focus on boosting the corporate value of Osstem Implant Co., once the PE manager and...
Feb 03, 2023 (Gmt+09:00)
Latest News
- 1 Invesco, SK D&D likely to buy co-living building in Seoul
- 2 Coupang bids for Korean luxury market dominance with Farfetch
- 3 Hyundai Rotem set to finalize $6 bn K2 tank order from Poland
- 4 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 5 Korea to allow non-profits to buy bad consumer loans